EDITAS MEDICINE

Editas Medicine is a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, and precise genomic medicines for a broad class of diseases... Success at Editas Medicine is driven by our exceptional team. We have intentionally built our company for and around the passionate scientists and experienced professionals who make our work possible. Together, we're translating groundbreaking science into transformative medicines... At Editas Medicine, we are pioneering the possible. Our mission and commitment is to harness the power and potential of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and..

Also known as: Editas Medicine, Inc.

Primary location: Cambridge United States